{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:29:16Z","timestamp":1762079356134},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1091,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1365-2133.2012.11122.x","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T15:14:10Z","timestamp":1341328450000},"page":"1118-1123","source":"Crossref","is-referenced-by-count":27,"title":["Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification"],"prefix":"10.1093","volume":"167","author":[{"given":"E.M.","family":"Bessell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Humber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.E.","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000478-199901000-00010","article-title":"Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features","volume":"23","author":"Baldassano","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.clindermatol.2010.04.005","article-title":"Pseudolymphoma and cutaneous lymphoma: facts and controversies","volume":"28","author":"Bergman","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2133.1998.02547.x","article-title":"Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?","volume":"139","author":"Russell-Jones","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.1996.14.2.549","article-title":"Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy","volume":"14","author":"Rijlaarsdam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients","volume":"17","author":"Bekkenk","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Dutch Cutaneous Lymphoma Group. Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H","article-title":"Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma","volume":"89","author":"Heinzerling","year":"2000","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB13|cit13","first-page":"1453","article-title":"Primary B-cell lymphoma of the skin: the Sheffield Lymphoma Group Experience (1984-2003)","volume":"25","author":"El-Helw","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajh.20019","article-title":"Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients","volume":"75","author":"Sah","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2340\/00015555-1112","article-title":"Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study","volume":"91","author":"Hallermann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1200\/JCO.2007.13.5376","article-title":"Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma","volume":"26","author":"Marcus","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/annonc\/mdg067","article-title":"Central Lymphoma Group UK. A randomised multicentre trial of modified CHOP vs. MCOP in patients aged 65\u2003years and over with aggressive non-Hodgkin\u2019s lymphoma","volume":"14","author":"Bessell","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1200\/JCO.2005.08.137","article-title":"The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00277-010-1083-1","article-title":"CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11)","volume":"90","author":"Mian","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1365-2133.2012.11122.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B cell lymphoma, leg type. Clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11122.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11122.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:56:35Z","timestamp":1676382995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/5\/1118\/6614179"}},"subtitle":["Prognosis of PCBCL subtypes"],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11122.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,5]]}}}